101 related articles for article (PubMed ID: 23304816)
1. Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometry.
Lim SM; Hwang JW; Bae SK; Bae SH; Ahn JB; Rha SY; Roh JK; Chung HC; Shin SJ
Anal Quant Cytopathol Histpathol; 2012 Dec; 34(6):309-16. PubMed ID: 23304816
[TBL] [Abstract][Full Text] [Related]
2. Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells.
Lim SM; Hwang JW; Ahn JB; Bae SK; Park CH; Kim KY; Rha SY; Chung HC; Roh JK; Shin SJ
Anticancer Res; 2013 Jun; 33(6):2499-508. PubMed ID: 23749901
[TBL] [Abstract][Full Text] [Related]
3. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
4. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
[TBL] [Abstract][Full Text] [Related]
5. Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors.
Chow S; Patel H; Hedley DW
Cytometry; 2001 Apr; 46(2):72-8. PubMed ID: 11309815
[TBL] [Abstract][Full Text] [Related]
6. XAF1 mediates apoptosis through an extracellular signal-regulated kinase pathway in colon cancer.
Yu LF; Wang J; Zou B; Lin MC; Wu YL; Xia HH; Sun YW; Gu Q; He H; Lam SK; Kung HF; Wong BC
Cancer; 2007 May; 109(10):1996-2003. PubMed ID: 17385215
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
8. Activation of extracellular signal-regulated kinase in trabecular meshwork cells.
Shearer T; Crosson CE
Exp Eye Res; 2001 Jul; 73(1):25-35. PubMed ID: 11428860
[TBL] [Abstract][Full Text] [Related]
9. Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines.
Marampon F; Gravina GL; Popov VM; Scarsella L; Festuccia C; La Verghetta ME; Parente S; Cerasani M; Bruera G; Ficorella C; Ricevuto E; Tombolini V; Di Cesare E; Zani BM
Int J Oncol; 2014 Jan; 44(1):285-94. PubMed ID: 24189697
[TBL] [Abstract][Full Text] [Related]
10. MEK inhibitor U0126 interferes with immunofluorescence analysis of apoptotic cell death.
Blank N; Burger R; Duerr B; Bakker F; Wohlfarth A; Dumitriu I; Kalden JR; Herrmann M
Cytometry; 2002 Aug; 48(4):179-84. PubMed ID: 12210141
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.
Beloueche-Babari M; Jackson LE; Al-Saffar NM; Workman P; Leach MO; Ronen SM
Cancer Res; 2005 Apr; 65(8):3356-63. PubMed ID: 15833869
[TBL] [Abstract][Full Text] [Related]
12. Orexin A induces autophagy in HCT-116 human colon cancer cells through the ERK signaling pathway.
Wen J; Zhao Y; Guo L
Int J Mol Med; 2016 Jan; 37(1):126-32. PubMed ID: 26572581
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
14. Quantitative NMR analysis of Erk activity and inhibition by U0126 in a panel of patient-derived colorectal cancer cell lines.
Rose HM; Stuiver M; Thongwichian R; Theillet FX; Feller SM; Selenko P
Biochim Biophys Acta; 2013 Jul; 1834(7):1396-401. PubMed ID: 23360766
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells.
Tong FK; Chow S; Hedley D
Cytometry B Clin Cytom; 2006 May; 70(3):107-14. PubMed ID: 16498671
[TBL] [Abstract][Full Text] [Related]
17. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events.
Krutzik PO; Nolan GP
Cytometry A; 2003 Oct; 55(2):61-70. PubMed ID: 14505311
[TBL] [Abstract][Full Text] [Related]
18. Effects of U0126 on growth and activation of mitogen-activated protein kinases in Aspergillus fumigatus.
Ma DM; Ji YJ; Yang F; Liu W; Wan Z; Li RY
Chin Med J (Engl); 2013 Jan; 126(2):220-5. PubMed ID: 23324267
[TBL] [Abstract][Full Text] [Related]
19. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
20. A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells.
Lee S; Yoon S; Kim DH
Gynecol Oncol; 2007 Feb; 104(2):338-44. PubMed ID: 17023032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
